Post Written By Gunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG. The cost of drug development has skyrocketed, but disruptive technologies can bring it back down to...
Read More
Nobody doubts that fake medicines are an increasing threat to consumers and the pharma industry’s bottom line. Is blockchain the answer to secure the supply chain? Counterfeit medicines are a multi-billion...
Read More
When a major global pharmaceutical company wanted to accelerate the development of a new therapy line and discover how to differentiate their early stage assets, they approached Innoplexus. That decision...
Read More
Medicine is ripe for disruption. As David Lawrence, former Chairman and CEO of the Kaiser Foundation Health Plan, wrote in his 2005 book chapter Bridging the Quality Chasm: “Between $.30 and $.40...
Read More
The entire pharmaceutical industry has been booming, from the manufacturing of clinical trial materials to support research studies to the regulated medicines on the pharmacy shelves. It has been one...
Read More
In the 21st century pharma companies face novel challenges. Pairing artificial intelligence (AI) capabilities with human strengths can bring a competitive edge in this rapidly–changing world. As the Nobel-prize-winning economist Daniel...
Read More
